Log in to save to my catalogue

Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast...

Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9fd0277ce8484dd4a5efb35306fd83e0

Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers

About this item

Full title

Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers

Publisher

England: BioMed Central Ltd

Journal title

Breast cancer research : BCR, 2025-01, Vol.27 (1), p.13-13, Article 13

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Pathological complete response (pCR) is an established surrogate marker for prognosis in patients with breast cancer (BC) after neoadjuvant chemotherapy. Individualized pCR prediction based on clinical information available at biopsy, particularly immunohistochemical (IHC) markers, may help identify patients who could benefit from preoperative chem...

Alternative Titles

Full title

Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9fd0277ce8484dd4a5efb35306fd83e0

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9fd0277ce8484dd4a5efb35306fd83e0

Other Identifiers

ISSN

1465-542X,1465-5411

E-ISSN

1465-542X

DOI

10.1186/s13058-025-01960-8

How to access this item